Trial intelligence / Profile preview

Bioavailability of Mucinex ER 600 mg in Fasted vs Fed Conditions

NCT03649750Phase 1Completed

Sponsor
Reckitt
Start
May 2013
Primary completion
Aug 2013
Modality
Small Molecules
01

Overview

Phase 1, randomised, open-label trial of acetaminophen in cough (2 arms), sponsored by Reckitt. Primary endpoints: Maximum Observed Plasma Concentration of Guaifenesin and Area Under Plasma Concentration-time Curve From Time 0 to Last Measurable Concentration. Started May 2013; status: completed.

02

Drugs

acetaminophen
03

Conditions

cough

Beyond the preview

Go deeper on NCT03649750.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03649750.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call